Back to Two Sigma Investments, LP Two Sigma Investments, LP

MRNAMRNA

Showing 8 of 22 quarters

Position history for Two Sigma Investments, LPTwo Sigma Investments, LP's holdings in Moderna, Inc.

Yes. Two Sigma Investments holds 7,193,530 shares of MRNA (Moderna), worth $503.8M, as of its Q2 2026 13F filing. It reduced the position by 1,892,874 shares (-20.8%) from Q1 2026. Two Sigma Investments has held MRNA since Q4 2023, across 11 quarterly 13F filings. MRNA is 0.4% of Two Sigma Investments' reported 13F portfolio.

Current Value

$503.8M

Current Shares

7.2M

Total Value Change

+$461.8M

Total Shares Change

+6.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
7.2M
-20.8%
$503.8M0.4%$70.03
0
2026-Q1
Increased
9.1M
+23.8%
$461.6M0.4%$50.80
45
2025-Q4
Decreased
7.3M
-2.5%
$216.5M0.3%$29.49
0
2025-Q3
Increased
7.5M
+8.2%
$194.5M0.3%$25.83
40
2025-Q2
Increased
7M
+56.2%
$192M0.3%$27.59
52
2025-Q1
Increased
4.5M
+570.8%
$126.3M0.3%$28.35
58
2024-Q4
Increased
664,040
+5.8%
$27.6M0.1%$41.58
30
2024-Q3
Increased
627,482
+3138.3%
$41.9M0.1%$65.75
47

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used